Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 1 Month to 36 Months

Effect of Dexmedetomidine on Sevoflurane in Young Children

Official title: Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

Run by Baylor College of Medicine · NCT03384563 · Data updated 2026-11-12

This study is testing how different doses of a medication called Dexmedetomidine can change the amount of anesthesia needed for young children during surgery.

More Pediatric Anesthesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages1 Month to 36 Months
SexAll
Enrollment180 (estimated)
SponsorBaylor College of Medicine
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedFebruary 18, 2018
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedSeptember 22, 2025
Trial IDNCT03384563 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 1 month to 3 years who are scheduled for surgery.

Probably not a fit

Patients with significant comorbidities such as congenital heart disease, central nervous system disorders, or those with a history of difficult intubation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate how two different dosages of Dexmedetomidine (0.5mcg/kg and 1mcg/kg) influence the minimum alveolar concentration (MAC) of Sevoflurane in children aged 1 month to 3 years. The MAC is a critical measure of anesthetic potency, indicating the dose required to prevent movement in response to surgical stimuli. By assessing the effects of Dexmedetomidine on MAC, the study seeks to optimize anesthesia protocols for pediatric patients undergoing surgery. The research will involve children from three age groups: 1-6 months, 6-12 months, and 12-36 months.

Why it matters

Potential benefit: If successful, this study could lead to improved anesthesia management in young children, enhancing safety and efficacy during surgical procedures.

How similar studies have gone: Previous studies have shown that Dexmedetomidine can effectively reduce the MAC of inhalational anesthetics in adults, suggesting potential success in pediatric applications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Exclusion Criteria:

1. Interstitial lung disease, chest wall disease, or bronchospastic disease with no flare-ups in the past 2 weeks of presentation
2. History of difficult intubation or ventilation
3. Airway malformation
4. Congenital heart disease
5. Cardiac arrhythmias
6. Central nervous system disease, including developmental delay, cerebral palsy, or seizure disorder
7. History of or family history of malignant hyperthermia
8. Electrolyte disorders
9. Gastrointestinal disease
10. Hepatic dysfunction
11. Renal dysfunction
12. Metabolic disease, such as diabetes
13. Obesity, defined as a body mass index greater than the 95% percentile for age
14. Preterm infant (less than 37 weeks gestational age) 15. Use of any medications (anticonvulsants, opioids, benzodiazepines, antibiotics, antihistamines drugs that induce hepatic enzymes) that may affect MAC.

Inclusion Criteria

All patients age 1 month- 3 years presenting for surgery.

Where it's running

  • Texas Children's Hospital
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Rahul Baijal, MD — Baylor College of Medicine
  • Study coordinator: Margaret Owens-Stuberfield
  • Email: owensstu@bcm.edu
  • Phone: 832-824-5800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.